Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 1/20 | 0.44 |
| ▸ | PDE10A | Q9Y233 | 9/20 | 0.42 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.41 |
| ▸ | SIRT1 | Q96EB6 | 2/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9288691 | 0.95 | PTGER4 (0.45) | PTGER4PDE10ASIRT2SIRT1ALOX5 | |
| SCHEMBL9288705 | 0.94 | ESR1 (0.41) | PTGER4PDE10ASIRT2SIRT1ALOX5 | |
| SCHEMBL9290171 | 0.94 | PTGER4 (0.40) | PTGER4PDE10ASIRT2SIRT1ALOX5 | |
| SCHEMBL9290151 | 0.93 | ALOX5 (0.42) | PTGER4SIRT2SIRT1ALOX5ALDH1A1 | |
| SCHEMBL459726 | 0.93 | ESR1 (0.44) | PTGER4SIRT2SIRT1ALOX5ALDH1A1 | |
| SCHEMBL9290156 | 0.92 | PTGER4 (0.42) | PTGER4PDE10ASIRT2SIRT1ALOX5 | |
| SCHEMBL9290101 | 0.92 | PTGER4 (0.43) | PTGER4PDE10ASIRT2SIRT1ALOX5 | |
| SCHEMBL15481551 | 0.91 | ESR1 (0.46) | PTGER4ALOX5ALDH1A1GAAESR1 | |
| SCHEMBL9288318 | 0.90 | PTGER4 (0.43) | PTGER4PDE10ASIRT2SIRT1ALOX5 | |
| SCHEMBL9288338 | 0.90 | ESR1 (0.46) | PTGER4ALOX5ALDH1A1GAAESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120133274-A1 | Carbazole Compound, Light-Emitting Element Material, Organic Semiconductor Material, Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-05-31 | — | — | US | disclosed |
| US-20120133274-A1 | Carbazole Compound, Light-Emitting Element Material, Organic Semiconductor Material, Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120133274-A1 | Carbazole Compound, Light-Emitting Element Material, Organic Semiconductor Material, Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device | BRI3BP, BRD7, CDYL | PTGER4 1970/4885PDE10A 3984/4885SIRT2 2906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.